OR WAIT null SECS
© 2023 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Check out the latest features and columns!
Ukraine invasion tests the resiliency and quick action of CROs and sponsors
ACT's biennial Salary Survey takes a look at the future of industry following increased adaptation of decentralized technology
May 25, 2023
Facility upgrade will support clinical supply demand for CGT development.
Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”
May 24, 2023
The adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Harsha K. Rajasimha, PhD, founder and executive chairman, IndoUSrare, provides the OCT audience insights into better achieving DEIA clinical trials.
In this Q&A, Craig Lipset offers additional insights following the announcement that CVS will be closing its clinical trial services business by the end of the year.
May 23, 2023
Allucent partners with THREAD to launch Allucent Patient Direct Trials, a DCT offering focused on small and mid-sized biotech companies.
New solution delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity.
UCB will adopt Veeva ePRO and Veeva eConsent.
May 22, 2023
New capability added to VIDA Intelligence Platform will streamline quality-controlled data curation.
In this Q&A, John Kastelein, MD, founder and chief scientific officer, NewAmsterdam Pharma, discusses the challenges and opportunities within the cardiovascular field, exploring the current landscape for lipid-lowering therapies and the unique potential advantages of CETP inhibitors.